{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:01:15Z","timestamp":1792425675708,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212029"],"award-info":[{"award-number":["7212029"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212030"],"award-info":[{"award-number":["7212030"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFC0121202"],"award-info":[{"award-number":["2019YFC0121202"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.neuroscience.2022.05.038","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T21:21:04Z","timestamp":1654204864000},"page":"96-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["NMO-IgG Induce Interleukin-6 Release via Activation of the NF-\u03baB Signaling Pathway in Astrocytes"],"prefix":"10.1016","volume":"496","author":[{"given":"Yupeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengri","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2022.05.038_b0005","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1242\/jcs.070896","article-title":"TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling","volume":"123","author":"Amasheh","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0010","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","article-title":"Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study","volume":"82","author":"Araki","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cytogfr.2012.09.001","article-title":"Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer","volume":"24","author":"Ataie-Kachoie","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/jamaneurol.2013.1246","article-title":"Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy","volume":"70","author":"Ayzenberg","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/cei.12733","article-title":"Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase","volume":"183","author":"Barros","year":"2016","journal-title":"Clin Exper Immunol"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0030","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0035","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0040","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.bbagen.2013.09.033","article-title":"Human aquaporins: regulators of transcellular water flow","volume":"1840","author":"Day","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0050","doi-asserted-by":"crossref","first-page":"118217","DOI":"10.1016\/j.lfs.2020.118217","article-title":"Effect of NMO-IgG on the interleukin-6 cascade in astrocytes via activation of the JAK\/STAT3 signaling pathway","volume":"258","author":"Du","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0060","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/glia.22635","article-title":"Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures","volume":"62","author":"Howe","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00207450903428970","article-title":"Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients","volume":"120","author":"\u0130\u0130\u00e7\u00f6z","year":"2010","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0070","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.2042-7158.2012.01529.x","article-title":"Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways","volume":"64","author":"Jia","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: passive transfer to rats by human immunoglobulin","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0080","article-title":"Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats","volume":"1","author":"Kitic","year":"2013","journal-title":"Acta Neuropathol Com"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0085","doi-asserted-by":"crossref","DOI":"10.2174\/1874467214666210301121432","article-title":"Connection between JAK\/STAT and PPARgamma signaling during the progression of multiple sclerosis: Insights into the modulation of T-cells and immune responses in the brain","author":"Kumar","year":"2021","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0090","article-title":"Astrocytic interleukin-15 reduces pathology of neuromyelitis optica in mice","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0095","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0100","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.3390\/ijms22147429","article-title":"The pivotal player: components of NF-\u03baB pathway as promising biomarkers in colorectal cancer","volume":"22","author":"Martin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0105","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","article-title":"Treatment of neuromyelitis optica: state-of-the-art and emerging therapies","volume":"10","author":"Papadopoulos","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0120","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaneurol.2015.0533","article-title":"Long-term therapy with interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder","volume":"72","author":"Ringelstein","year":"2015","journal-title":"Jama Neurol"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0092-8674(86)90807-X","article-title":"Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism","volume":"47","author":"Sen","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0135","first-page":"e311","article-title":"Effects of neuromyelitis optica\u2013IgG at the blood\u2013brain barrier in vitro","volume":"4","author":"Takeshita","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0140","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.7150\/ijbs.4666","article-title":"Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases","volume":"8","author":"Tanaka","year":"2012","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0145","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1177\/1352458516672015","article-title":"Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption","volume":"23","author":"Uchida","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0150","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"Uzawa","year":"2010","journal-title":"Mult Scler J"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(99)00187-3","article-title":"Interleukin-6 expression and regulation in astrocytes","volume":"100","author":"Van Wagoner","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0160","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1523\/JNEUROSCI.19-13-05236.1999","article-title":"Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor","volume":"19","author":"Van Wagoner","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0403-8","article-title":"NF\u03baB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG","volume":"12","author":"Walker-Caulfield","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2022.05.038_b0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222002858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222002858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:12:29Z","timestamp":1759680749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452222002858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":33,"alternative-id":["S0306452222002858"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.05.038","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NMO-IgG Induce Interleukin-6 Release via Activation of the NF-\u03baB Signaling Pathway in Astrocytes","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd on behalf of IBRO.","name":"copyright","label":"Copyright"}]}}